![Jeffrey Nau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Nau
Vorstandsvorsitzender bei
Aviceda Therapeutics, Inc.
Profil
Jeffrey A. Nau is President, Chief Executive Officer & Director at Aviceda Therapeutics, Inc. since 2025.
Treasurer & Director at BioNJ, Inc. since 2020.
Director at Ophthalmology Foundation since 2023.
Formerly President & Chief Executive Officer at Oyster Point Pharma, Inc. from 2017 to 2023.
Vice President-Clinical & Medical Affairs at IVERIC bio, Inc. from 2013 to 2017.
Director-Medical Sciences at Genentech, Inc. from 2011 to 2013.
Vice President-Medical & Clinical Affairs at NeoVista, Inc. from 2006 to 2011.
Chief Operating Officer at Kalaris Therapeutics, Inc. in 2025.
Clinical Program Manager at Genaera Pharmaceuticals.
Research Fellow at Wills Eye Health System & Wills Eye Institute.
President-Eye Care Division at Viatris, Inc. Education includes a doctorate from Walden University LLC, graduate degree from Drexel University College of Medicine, and undergraduate degree from Stony Brook University.
Aktive Positionen von Jeffrey Nau
| Unternehmen | Position | Beginn |
|---|---|---|
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Direktor/Vorstandsmitglied | 13.02.2020 |
Ophthalmology Foundation
 Ophthalmology Foundation Miscellaneous Commercial ServicesCommercial Services The Ophthalmology Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing ophthalmic education and improving eye care worldwide, with a focus on underserved and low-resource regions. The private company is based in San Francisco, CA. The organization empowers vision care through accessible, high-quality education, faculty development, and professional growth for ophthalmologists and eye care professionals. Key initiatives include internationally recognized, low-cost online examinations aligned with American Academy of Ophthalmology standards, offered biannually at local host centers worldwide to reduce travel barriers. The foundation plans to expand exam offerings with new subspecialty tests in retina and glaucoma launching in 2027. Top-performing candidates outside the U.S. may receive travel grants to attend international conferences or pursue specialized training. Faculty development is a core focus, with programs designed to enhance teaching skills through mentorships, symposia, workshops, webinars, simulation-based education, and online courses offering continuing professional development credits. The foundation’s educator’s certificate program certifies teaching competence, enabling educators to participate as faculty in educational interventions. Its faculty development committee oversees program quality and volunteer recruitment. Additional offerings include subspecialty fellowships awarding 80-100 grants annually across 20 areas, accreditation of residency programs to meet international standards, and collaborative partnerships with leading institutions and organizations worldwide. The foundation emphasizes equity, inclusion, and ethical standards, tailoring programs to regional needs through an international advisory committee. | Direktor/Vorstandsmitglied | 29.06.2023 |
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Vorstandsvorsitzender | 01.04.2025 |
Ehemalige bekannte Positionen von Jeffrey Nau
| Unternehmen | Position | Ende |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01.01.2024 |
| OYSR POIN | Vorstandsvorsitzender | 01.01.2023 |
| IVERIC BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2013 |
Ausbildung von Jeffrey Nau
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
NeoVista, Inc.
 NeoVista, Inc. Medical SpecialtiesHealth Technology Develops a device-based therapy for age-related macular degeneration | Health Technology |
Walden University LLC
 Walden University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genaera Pharmaceuticals | |
Wills Eye Health System & Wills Eye Institute
 Wills Eye Health System & Wills Eye Institute Medical/Nursing ServicesHealth Services Operates eye hospital | Health Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases | Health Technology |
Viatris, Inc.
 Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Ophthalmology Foundation
Ophthalmology Foundation Miscellaneous Commercial ServicesCommercial Services The Ophthalmology Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing ophthalmic education and improving eye care worldwide, with a focus on underserved and low-resource regions. The private company is based in San Francisco, CA. The organization empowers vision care through accessible, high-quality education, faculty development, and professional growth for ophthalmologists and eye care professionals. Key initiatives include internationally recognized, low-cost online examinations aligned with American Academy of Ophthalmology standards, offered biannually at local host centers worldwide to reduce travel barriers. The foundation plans to expand exam offerings with new subspecialty tests in retina and glaucoma launching in 2027. Top-performing candidates outside the U.S. may receive travel grants to attend international conferences or pursue specialized training. Faculty development is a core focus, with programs designed to enhance teaching skills through mentorships, symposia, workshops, webinars, simulation-based education, and online courses offering continuing professional development credits. The foundation’s educator’s certificate program certifies teaching competence, enabling educators to participate as faculty in educational interventions. Its faculty development committee oversees program quality and volunteer recruitment. Additional offerings include subspecialty fellowships awarding 80-100 grants annually across 20 areas, accreditation of residency programs to meet international standards, and collaborative partnerships with leading institutions and organizations worldwide. The foundation emphasizes equity, inclusion, and ethical standards, tailoring programs to regional needs through an international advisory committee. | Commercial Services |
